Gaofeng Shu

3.5k total citations · 2 hit papers
68 papers, 2.8k citations indexed

About

Gaofeng Shu is a scholar working on Biomedical Engineering, Molecular Biology and Biomaterials. According to data from OpenAlex, Gaofeng Shu has authored 68 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Biomedical Engineering, 18 papers in Molecular Biology and 13 papers in Biomaterials. Recurrent topics in Gaofeng Shu's work include Nanoplatforms for cancer theranostics (25 papers), Proteins in Food Systems (12 papers) and Nanoparticle-Based Drug Delivery (12 papers). Gaofeng Shu is often cited by papers focused on Nanoplatforms for cancer theranostics (25 papers), Proteins in Food Systems (12 papers) and Nanoparticle-Based Drug Delivery (12 papers). Gaofeng Shu collaborates with scholars based in China, Japan and Pakistan. Gaofeng Shu's co-authors include Yongzhong Du, Jiansong Ji, Jing Qi, Mitsutoshi Nakajima, Nauman Khalid, Di Liu, Feiyang Jin, Xiaoying Ying, Xiaoling Xu and Isao Kobayashi and has published in prestigious journals such as Advanced Materials, Nature Communications and Nano Letters.

In The Last Decade

Gaofeng Shu

67 papers receiving 2.7k citations

Hit Papers

ROS-responsive nano-drug delivery system combining mitoch... 2020 2026 2022 2024 2020 2023 50 100 150 200 250

Peers

Gaofeng Shu
Xia Cao China
Yao Fu China
Farhad Rezaee Netherlands
Xue Yang China
Gaofeng Shu
Citations per year, relative to Gaofeng Shu Gaofeng Shu (= 1×) peers Daquan Chen

Countries citing papers authored by Gaofeng Shu

Since Specialization
Citations

This map shows the geographic impact of Gaofeng Shu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gaofeng Shu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gaofeng Shu more than expected).

Fields of papers citing papers by Gaofeng Shu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gaofeng Shu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gaofeng Shu. The network helps show where Gaofeng Shu may publish in the future.

Co-authorship network of co-authors of Gaofeng Shu

This figure shows the co-authorship network connecting the top 25 collaborators of Gaofeng Shu. A scholar is included among the top collaborators of Gaofeng Shu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gaofeng Shu. Gaofeng Shu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Yaning, Weiqian Chen, Xiaoxiao Chen, et al.. (2025). Immune-activated microspheres for enhanced chemoembolization of hepatocellular carcinoma by blocking the adenosine A2A receptor. Acta Biomaterialia. 199. 443–455. 4 indexed citations
2.
Gong, Fei, Yuqi Yang, Zifan Pei, et al.. (2025). A Gas Nanobomb to Promote Drug Penetration and Amplify TACE Therapy for Orthotopic Liver Tumor. Advanced Materials. 37(39). e2505770–e2505770. 3 indexed citations
3.
Chen, Xiaoxiao, Muhammad Sohail, Fazong Wu, et al.. (2024). Self-targeted smart polyester nanoparticles for simultaneous Delivery of photothermal and chemotherapeutic agents for efficient treatment of HCC. Biomaterials Science. 12(24). 6368–6381.
5.
Yang, Zhijuan, Yi Zhong, Xiaoxiao Chen, et al.. (2024). Cholesterol Targeted Catalytic Hydrogel Fueled by Tumor Debris can Enhance Microwave Ablation Therapy and Anti‐Tumor Immune Response. Advanced Science. 12(5). e2406975–e2406975. 7 indexed citations
6.
Zheng, Liyun, Shiji Fang, Jiale Chen, et al.. (2024). Potentiated Calcium Carbonate with Enhanced Calcium Overload Induction and Acid Neutralization Capabilities to Boost Chemoimmunotherapy against Liver Cancer. ACS Nano. 18(40). 27597–27616. 19 indexed citations
7.
Chen, Weiyue, Jiayi Ding, Gaofeng Shu, et al.. (2023). The role of metabolic reprogramming of oxygen‐induced macrophages in the dynamic changes of atherosclerotic plaques. The FASEB Journal. 37(3). e22791–e22791. 15 indexed citations
8.
Shen, Qiying, Quan Hu, Ting Tang, et al.. (2022). ICAM-1 targeted thermal-sensitive micelles loaded with tofacitinib for enhanced treatment of rheumatoid arthritis via microwave assistance. Biomaterials Advances. 138. 212940–212940. 10 indexed citations
9.
Zhang, Nannan, Gaofeng Shu, Enqi Qiao, et al.. (2022). DNA-Functionalized Liposomes In Vivo Fusion for NIR-II/MRI Guided Pretargeted Ferroptosis Therapy of Metastatic Breast Cancer. ACS Applied Materials & Interfaces. 14(18). 20603–20615. 17 indexed citations
10.
Chen, Minjiang, Gaofeng Shu, Xiuling Lv, et al.. (2022). HIF-2α-targeted interventional chemoembolization multifunctional microspheres for effective elimination of hepatocellular carcinoma. Biomaterials. 284. 121512–121512. 45 indexed citations
11.
Kong, Chunli, Zhongwei Zhao, Weiyue Chen, et al.. (2021). Prediction of tumor response via a pretreatment MRI radiomics-based nomogram in HCC treated with TACE. European Radiology. 31(10). 7500–7511. 97 indexed citations
12.
Chen, Minjiang, Xiaoling Xu, Gaofeng Shu, et al.. (2021). Multifunctional Microspheres Dual-Loaded with Doxorubicin and Sodium Bicarbonate Nanoparticles to Introduce Synergistic Trimodal Interventional Therapy. ACS Applied Bio Materials. 4(4). 3476–3489. 11 indexed citations
13.
Wang, Jun, Jing Qi, Feiyang Jin, et al.. (2021). Spatiotemporally light controlled “drug-free” macromolecules via upconversion-nanoparticle for precise tumor therapy. Nano Today. 42. 101360–101360. 16 indexed citations
14.
Liu, Di, Gaofeng Shu, Feiyang Jin, et al.. (2020). ROS-responsive chitosan-SS31 prodrug for AKI therapy via rapid distribution in the kidney and long-term retention in the renal tubule. Science Advances. 6(41). 161 indexed citations
15.
Yu, Hui, Feiyang Jin, Di Liu, et al.. (2020). ROS-responsive nano-drug delivery system combining mitochondria-targeting ceria nanoparticles with atorvastatin for acute kidney injury. Theranostics. 10(5). 2342–2357. 266 indexed citations breakdown →
16.
Shu, Gaofeng, Chenying Lu, Zhixian Wang, et al.. (2020). Fucoidan-based micelles as P-selectin targeted carriers for synergistic treatment of acute kidney injury. Nanomedicine Nanotechnology Biology and Medicine. 32. 102342–102342. 27 indexed citations
17.
Jin, Feiyang, Jing Qi, Minxia Zhu, et al.. (2020). NIR-Triggered Sequentially Responsive Nanocarriers Amplified Cascade Synergistic Effect of Chemo-Photodynamic Therapy with Inspired Antitumor Immunity. ACS Applied Materials & Interfaces. 12(29). 32372–32387. 43 indexed citations
18.
Shu, Gaofeng, Nauman Khalid, Zhang Chen, et al.. (2018). Formulation and characterization of astaxanthin-enriched nanoemulsions stabilized using ginseng saponins as natural emulsifiers. Food Chemistry. 255. 67–74. 68 indexed citations
19.
Zhao, Yiguo, Nauman Khalid, Gaofeng Shu, et al.. (2017). Formulation and characterization of oil-in-water emulsions stabilized by gelatinized kudzu starch. International Journal of Food Properties. 1–13. 23 indexed citations
20.
Khalid, Nauman, Gaofeng Shu, Isao Kobayashi, Mitsutoshi Nakajima, & Colin J. Barrow. (2017). Formulation and characterization of monodisperse O/W emulsions encapsulating astaxanthin extracts using microchannel emulsification: Insights of formulation and stability evaluation. Colloids and Surfaces B Biointerfaces. 157. 355–365. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026